GPCRStructure Therapeutics Inc. American Depositary Shares
49.09USD-9.31%Mkt Cap: 3.50B $P/E: —3d ago
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap3.50B $
Enterprise Value2.27B $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-141.20M $
Revenue/Share—
Last Price49.09 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees281
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-23.89
PEG—
EV/EBITDA-8.53
EV/Revenue—
P/S—
P/B2.36
EPS (TTM)-2.84
EPS (Forward)-2.11
52W Range
18.2640% of range94.90
52W High94.90 USD
52W Low18.26 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-9.31%
ROA-8.91%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-222.20M $
CapEx (TTM)3.61M $
FCF Margin—
FCF Yield-3.40%
Net Debt-1.34B $
Net Debt/EBITDA5.03
Balance Sheet
Debt/Equity0.00
Current Ratio20.75
Quick Ratio20.31
Book Value/Sh21.41 USD
Cash/Share18.83 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)104.77 USD
Upside (mean)+113.4%
Target Range69.50 USD – 145.00 USD
$69.50+113.4% to mean$145.00
# Analysts15
Ownership
Shares Out.71.31M
Float54.64M
Insiders2.85%
Institutions97.08%
Short Interest
Short Ratio9.4d
Short % Float11.67%
Short % Out.8.51%
Shares Short6.05M
Short (prev mo.)6.13M
Technical
SMA 5049.92 (-1.7%)
SMA 20053.62 (-8.4%)
Beta-1.51
S&P 52W Chg18.16%
Avg Vol (30d)525.54K
Avg Vol (10d)680.09K
Technical Indicators
RSI (14)44.5
MACD1.1097
MACD Signal1.2140
MACD Hist.-0.1043
BB Upper56.19 USD
BB Middle51.08 USD
BB Lower45.98 USD
BB Width19.99%
ATR (14)2.665 USD
Vol Ratio (20d)1.17x